These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8746555)
1. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders. Ebadi M; Srinivasan SK Pharmacol Rev; 1995 Dec; 47(4):575-604. PubMed ID: 8746555 [No Abstract] [Full Text] [Related]
2. [Calamities in movement disorders]. Mínguez-Castellanos A Neurologia; 2010 Oct; 25 Suppl 1():24-9. PubMed ID: 21129594 [TBL] [Abstract][Full Text] [Related]
3. Movement disorders emergencies. Part 1: Hypokinetic disorders. Robottom BJ; Weiner WJ; Factor SA Arch Neurol; 2011 May; 68(5):567-72. PubMed ID: 21555633 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced movement disorders: an overview. Sachdev PS Psychiatr Clin North Am; 2005 Mar; 28(1):255-74, x. PubMed ID: 15733622 [No Abstract] [Full Text] [Related]
5. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal. Thomas A; Onofrj M Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099 [No Abstract] [Full Text] [Related]
6. [Abnormal movements in children. 2 cases of known etiology but infrequent: Sandifer syndrome and a syndrome caused by neuroleptics]. Fenellós Fernández V; García Vicent C; Castro Rodríguez JM; Sanz Ortega J; León Sebastiá P An Esp Pediatr; 1986 Nov; 25(5):367-71. PubMed ID: 3813229 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome in striatonigral degeneration. Itoh M; Nakano E; Ieshima A; Takeshita K Pediatr Neurol; 1995 Oct; 13(3):255-6. PubMed ID: 8554665 [TBL] [Abstract][Full Text] [Related]
8. Pediatric movement disorders. Saunders-Pullman R; Braun I; Bressman S Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):747-65, viii. PubMed ID: 10553201 [TBL] [Abstract][Full Text] [Related]
9. [Studies of risk factors and preventive care for neuroleptic malignant syndrome]. Tanii H Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842 [TBL] [Abstract][Full Text] [Related]
10. Contractures in neuroleptic malignant syndrome. Craddock B; Craddock N Am J Psychiatry; 1997 Mar; 154(3):436. PubMed ID: 9054799 [No Abstract] [Full Text] [Related]
11. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state. Rock W; Elias M; Lev A; Saliba WR Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome induced by metoclopramide in an infant with Freeman-Sheldon syndrome. Stein MH; Sorscher M; Caroff SN Anesth Analg; 2006 Sep; 103(3):786-7. PubMed ID: 16931708 [No Abstract] [Full Text] [Related]
17. Rare neuropsychiatric sequelae following neuroleptic malignant syndrome: a case report and review of the literature. Chan LG; Lee J; Ng BT; Chua HC; Sim K; Lee EL Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1998-9. PubMed ID: 18727947 [No Abstract] [Full Text] [Related]
18. Common toxidromes in movement disorder neurology. Malek N; Baker MR Postgrad Med J; 2017 Jun; 93(1100):326-332. PubMed ID: 28546460 [TBL] [Abstract][Full Text] [Related]